Privia Health Group (NASDAQ:PRVA – Get Free Report) and Azenta (NASDAQ:AZTA – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership.
Earnings and Valuation
This table compares Privia Health Group and Azenta”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Privia Health Group | $1.74 billion | 1.56 | $14.39 million | $0.13 | 169.31 |
| Azenta | $593.82 million | 2.21 | -$55.76 million | ($1.30) | -21.92 |
Institutional & Insider Ownership
94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 99.1% of Azenta shares are held by institutional investors. 10.7% of Privia Health Group shares are held by insiders. Comparatively, 10.9% of Azenta shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of current ratings and price targets for Privia Health Group and Azenta, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Privia Health Group | 0 | 3 | 13 | 0 | 2.81 |
| Azenta | 1 | 3 | 4 | 0 | 2.38 |
Privia Health Group currently has a consensus target price of $30.50, indicating a potential upside of 38.57%. Azenta has a consensus target price of $42.17, indicating a potential upside of 48.01%. Given Azenta’s higher probable upside, analysts plainly believe Azenta is more favorable than Privia Health Group.
Volatility and Risk
Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Azenta has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500.
Profitability
This table compares Privia Health Group and Azenta’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Privia Health Group | 0.89% | 2.52% | 1.47% |
| Azenta | -10.01% | 1.40% | 1.17% |
Summary
Privia Health Group beats Azenta on 9 of the 14 factors compared between the two stocks.
About Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
About Azenta
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
